Dermatol. praxi. 2022;16(2):79-84 | DOI: 10.36290/der.2022.015

Diseases of the scalp and scalp care

MUDr. Veronika Šelingerová
Dermatovenerologická klinika 1. LF UK a VFN v Praze

Diseases of the scalp are a common problem encountered by dermatologists. Due to the chronic course of these conditions, the goal is to provide treatment which is not only effective and safe in the long term, but also well tolerated by the patient. In this respect, a well-chosen combination of local therapy and scalp care may be the key to success. It is the patient's tolerance to treatment and its cosmetic acceptability that are among the main pitfalls that often hinder successful treatment. The article presents an overview of selected diseases of the scalp and their treatment, taking into account efficacy in terms of daily care.

Keywords: eczematous manifestations in the scalp, scalp psoriasis vulgaris, folliculitis, diffuse hair loss.

Published: June 7, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šelingerová V. Diseases of the scalp and scalp care. Dermatol. praxi. 2022;16(2):79-84. doi: 10.36290/der.2022.015.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Suchánková D. Choroby postihující kůži kštice. Čas Lék Čes. 2017;156(3):137-140.
    2. Třešňák Hercogová J, et al. Klinická dermatovenerologie. Praha: Mladá fronta, 2019. Medical services. ISBN 978-80-204-5321-1.
    3. Obstová I. Etiopatogeneze a terapie acne vulgaris. Klin Farmakol Farm. 2015;29(2):69-72.
    4. Gavazzoni Dias MF. Hair cosmetics: an overview. Int J Trichology. 2015;7(1):2-15. Go to original source... Go to PubMed...
    5. Mojsiewicz-Pieńkowska K, Stachowska E, Krenczkowska D, Bazar D, Meijer F. Evidence of Skin Barrier Damage by Cyclic Siloxanes (Silicones)-Using Digital Holographic Microscopy. Int J Mol Sci. 2020;21(17):6375. Go to original source... Go to PubMed...
    6. Nevoralová Z, Rulcová J, Benáková N. Obličejové dermatózy. 2., přepracované a doplněné vydání. Praha: Mladá fronta, 2018. Aeskulap. ISBN 9788020448910.
    7. Vojáčková N. Seboroická dermatitida, diferenciální diagnostika a léčba v praxi. Med Praxi. 2017;14(4):185-188. Go to original source...
    8. Viktorinová M. Seboroická dermatitída. Med. praxi. 2005;4: 161-166.
    9. Finsterlová M. Nemoci vlasů. Interní Med. 2008;10(10): 474-477. Go to original source... Go to PubMed...
    10. Cirmanová V, Stárka L. Asociace alopecia areata s autoimunitní tyreoiditidou u 17leté dívky. Med. Pro Praxi. 2006; 6:294-295.
    11. Benáková N. Léčba atopické dermatitidy/ekzému u dospělýc. Med. Pro Praxi. 2010;7(5):221-228.
    12. Machovcová A. Kontaktní dermatitidy. Med. Pro Praxi. 2008;5(9):325-328.
    13. Paťavová V, Drlík L. Folikulárně vázané záněty kůže. Dermatol. Praxi. 2014;8(1):15-16.
    14. Tichý M, Ditrichová D. Psoriáza kštice a aktuální léčebné možnosti. Dermatol. Praxi. 2010;4(3):131-135.
    15. Ditrichová D. Ichtamol a dehty v současné dermatologické terapii. Klin. Farmakol. Farm. 2005;19:47-48.
    16. Česká dermatovenerologická společnost. Zápis z on-line schůze výboru ČDS konané dne 13.5.2021. Available from: https://www.derm.cz/vybor/zapisy-ze-schuzi/13-5-2021/.
    17. Marques E, Tanczosová M, Arenbergerová M. Alopecie - přehled, příčiny a současné možnosti léčby. Dermatol. praxi. 2020;14(3):124-132. Go to original source...
    18. Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Ir J Med Sci. 2021;31:1-5. Go to original source... Go to PubMed...
    19. Kučerová R. Difuzní řídnutí vlasů. Dermatol. praxi. 2013;7(2):56-59.
    20. Romero JAM, Grimalt R. Trichoscopy: Essentials for the dermatologist. World J Dermatol. 2015;4(2):63-68. Go to original source...
    21. Státní ústav pro kontrolu léčiv. Available from:https://www.sukl.cz/modules/medication/detail.php?code=0218841&tab=texts.
    22. Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol. 2018;57(1):104-109. Go to original source... Go to PubMed...
    23. Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review [published correction appears in Drug Des Devel Ther. 2020;14:575]. Go to original source... Go to PubMed...
    24. Martinásková J. Farmaceutická péče o pacienty s vypadáváním vlasů. Dermatol. praxi 2015;9(4):188-190.
    25. Zhou Y, Chen C, Qu Q, Zhang C, Wang J, Fan Z, Miao Y, Hu Z. The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis. Dermatol Ther. 2020;33(4):e13741. Go to original source... Go to PubMed...
    26. Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. JADV. 2022;36(2):286-294. Go to original source... Go to PubMed...
    27. Duchoňová M. Poruchy rastu vlasov. Čes. Dermatovenerol. 2018;8(3):158-172.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.